Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven D Rhodes

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Human Molecular Genetics|August 13, 2014
A murine model of neurofibromatosis type 2 that accurately phenocopies human schwannoma formationJeffrey R Gehlhausen, Su-Jung Park, Ann E Hickox, et al.
British Journal of Cancer|March 4, 2021
Exploring transcriptional regulators Ref-1 and STAT3 as therapeutic targets in malignant peripheral nerve sheath tumoursSilpa Gampala, Fenil Shah, Chi Zhang, et al.
Science Advances|January 30, 2026
Inhibition of focal adhesion kinase impairs tumor formation and preserves hearing in a murine model of NF2-related schwannomatosisDana K Mitchell, Kylee Brewster, Li Jiang, et al.
Science Advances|June 20, 2025
TGFβ-dependent signaling drives tumor growth and aberrant extracellular matrix dynamics in NF1-associated plexiform neurofibromaMohannad Abu-Sultanah, Zhuan Zhou, Chunhui Jiang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 21, 2023
Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor ProgressionDana K Mitchell, Breanne Burgess, Emily E White, et al.
Human Molecular Genetics|October 19, 2018
A proteasome-resistant fragment of NIK mediates oncogenic NF-κB signaling in schwannomasJeffrey R Gehlhausen, Eric Hawley, Benjamin Mark Wahle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 5, 2023
Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform NeurofibromaAlyssa C Flint, Dana K Mitchell, Steven P Angus, et al.
Nature Medicine|January 14, 2021
Cabozantinib for neurofibromatosis type 1-related plexiform neurofibromas: a phase 2 trialMichael J Fisher, Chie-Schin Shih, Steven D Rhodes, et al.
Nature Medicine|January 6, 2025
Selumetinib in adults with NF1 and inoperable plexiform neurofibroma: a phase 2 trialAndrea M Gross, Geraldine O'Sullivan Coyne, Eva Dombi, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Human Molecular Genetics|August 13, 2014
A murine model of neurofibromatosis type 2 that accurately phenocopies human schwannoma formationJeffrey R Gehlhausen, Su-Jung Park, Ann E Hickox, et al.
British Journal of Cancer|March 4, 2021
Exploring transcriptional regulators Ref-1 and STAT3 as therapeutic targets in malignant peripheral nerve sheath tumoursSilpa Gampala, Fenil Shah, Chi Zhang, et al.
Science Advances|January 30, 2026
Inhibition of focal adhesion kinase impairs tumor formation and preserves hearing in a murine model of NF2-related schwannomatosisDana K Mitchell, Kylee Brewster, Li Jiang, et al.
Science Advances|June 20, 2025
TGFβ-dependent signaling drives tumor growth and aberrant extracellular matrix dynamics in NF1-associated plexiform neurofibromaMohannad Abu-Sultanah, Zhuan Zhou, Chunhui Jiang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 21, 2023
Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor ProgressionDana K Mitchell, Breanne Burgess, Emily E White, et al.
Human Molecular Genetics|October 19, 2018
A proteasome-resistant fragment of NIK mediates oncogenic NF-κB signaling in schwannomasJeffrey R Gehlhausen, Eric Hawley, Benjamin Mark Wahle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 5, 2023
Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform NeurofibromaAlyssa C Flint, Dana K Mitchell, Steven P Angus, et al.
Nature Medicine|January 14, 2021
Cabozantinib for neurofibromatosis type 1-related plexiform neurofibromas: a phase 2 trialMichael J Fisher, Chie-Schin Shih, Steven D Rhodes, et al.
Nature Medicine|January 6, 2025
Selumetinib in adults with NF1 and inoperable plexiform neurofibroma: a phase 2 trialAndrea M Gross, Geraldine O'Sullivan Coyne, Eva Dombi, et al.
Pageof 5